The Institute for Biotechnology and Medicine Industry said Tuesday it has developed a safer and more convenient vaccine against human respiratory syncytial virus (RSV), which causes tens of millions of infections worldwide every year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Nymphia Wind makes history by triumphing on RuPaul's Drag Race
04/20/2024 03:18 PM - Sports
Taiwan's gymnast Lee Chih-kai 'burnt out' after hope for Paris dims
04/20/2024 03:05 PM - Cross-Strait
17 PLA aircraft cross Taiwan Strait median line or extension: Ministry
04/20/2024 12:57 PM - Business
Tech expert and witness to semiconductor boom, urges Taiwan to think big
04/20/2024 12:50 PM - Society
Taiwan to soon welcome its first indigenous dog as a police canine
04/20/2024 12:43 PM